| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $170.9M | +0.4% |
| SG&A Expense | $47.6M | +4.0% |
| Operating Income | -$218.6M | -1.1% |
| Interest Expense | $13.9M | -28.6% |
| Pre-tax Income | -$229.4M | +2.0% |
| Net Income | -$229.4M | +2.0% |
| EPS (Basic) | -$2.71 | +13.4% |
| EPS (Diluted) | -$2.71 | +13.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.0M | -38.9% |
| Short-term Investments | $143.7M | +1.3% |
| Current Assets | $261.9M | -21.1% |
| Total Assets | $272.4M | -20.7% |
| Current Liabilities | $49.2M | +23.5% |
| Long-term Debt | $12.0M | -58.8% |
| Total Liabilities | $260.4M | +17.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$187.0M | +1.0% |
| Capital Expenditures | $410K | -73.5% |
| Investing Cash Flow | -$1.0M | +99.1% |
| Financing Cash Flow | $117.1M | +3417.3% |
| Free Cash Flow | -$187.4M | +1.6% |
| Stockholders' Equity |
| $12.1M |
| -90.1% |